Suppr超能文献

中国356例三阴性乳腺癌患者的临床特征及预后分析

Analysis of Clinical Features and Outcome of 356 Triple-Negative Breast Cancer Patients in China.

作者信息

Zhang Li, Hao Chunfang, Dong Guolei, Tong Zhongsheng

机构信息

Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Cancer Research Key Laboratory of Education Ministry, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin, China.

出版信息

Breast Care (Basel). 2012 Feb;7(1):13-17. doi: 10.1159/000336539. Epub 2012 Feb 13.

Abstract

BACKGROUND

The purpose of this study was to investigate the clinicopathological features and analyze the prognostic factors of triple-negative breast cancer (TNBC). PATIENTS AND METHODS: The clinical data of 1,788 breast cancer patients was collected and analyzed. The Kaplan-Meier method was used to estimate survival. Multivariate analysis of the prognostic factors for survival was performed using the Cox regression model. RESULTS: Patients with TNBC exhibited characteristics significantly differing from those with non-TNBC. There was a higher proportion of patients with age < 35 years, stage III disease, tumor size > 5 cm, lymph node positivity, and histological grade 3. The 5-year disease-free survival (DFS) rates of TNBC and non-TNBC patients were 75.7 and 79.6%, respectively (p < 0.05). 5-year overall survival (OS) was 86.6 and 93.5%, respectively (p < 0.05). In multivariate Cox regression analysis, the independent prognostic factors for shorter DFS were age < 35 years (hazard ratio (HR) 2.105), positive lymph nodes (HR 7.039), histological grade 3 (HR 1.841), and for shorter OS positive lymph nodes (HR 4.626). CONCLUSION: The proportion of TNBC in breast cancer in China is higher than in other areas. TNBC is correlated with younger age, larger tumor size, positive lymph nodes, higher clinical stage and histological grade, and lower DFS and OS, which is consistent with previous reports.

摘要

背景

本研究旨在探讨三阴性乳腺癌(TNBC)的临床病理特征并分析其预后因素。

患者与方法

收集并分析1788例乳腺癌患者的临床资料。采用Kaplan-Meier法估计生存率。使用Cox回归模型对生存预后因素进行多变量分析。

结果

TNBC患者表现出与非TNBC患者显著不同的特征。年龄<35岁、Ⅲ期疾病、肿瘤大小>5cm、淋巴结阳性和组织学3级的患者比例更高。TNBC和非TNBC患者的5年无病生存率(DFS)分别为75.7%和79.6%(p<0.05)。5年总生存率(OS)分别为86.6%和93.5%(p<0.05)。在多变量Cox回归分析中,DFS较短的独立预后因素为年龄<35岁(风险比(HR)2.105)、淋巴结阳性(HR 7.039)、组织学3级(HR 1.841),OS较短的独立预后因素为淋巴结阳性(HR 4.626)。

结论

中国乳腺癌中TNBC的比例高于其他地区。TNBC与较年轻的年龄、较大的肿瘤大小、淋巴结阳性、较高的临床分期和组织学分级相关,且DFS和OS较低,这与先前的报道一致。

相似文献

1
Analysis of Clinical Features and Outcome of 356 Triple-Negative Breast Cancer Patients in China.
Breast Care (Basel). 2012 Feb;7(1):13-17. doi: 10.1159/000336539. Epub 2012 Feb 13.
3
5
The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients.
Onco Targets Ther. 2016 Sep 19;9:5751-5759. doi: 10.2147/OTT.S113768. eCollection 2016.
6
The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience.
J Breast Health. 2014 Oct 1;10(4):209-215. doi: 10.5152/tjbh.2014.1904. eCollection 2014 Oct.
7
8
Clinicopathological features of triple-negative breast cancer in Taiwanese women.
Int J Clin Oncol. 2011 Oct;16(5):500-5. doi: 10.1007/s10147-011-0211-9. Epub 2011 Apr 1.
9
Clinical characteristics and prognostic analysis of triple-negative breast cancer patients.
Mol Clin Oncol. 2014 Mar;2(2):245-251. doi: 10.3892/mco.2013.230. Epub 2013 Dec 20.

引用本文的文献

1
Identifying cancer subtypes based on embryonic and hematopoietic stem cell signatures in pan-cancer.
Cell Oncol (Dordr). 2024 Apr;47(2):587-605. doi: 10.1007/s13402-023-00886-7. Epub 2023 Oct 12.
4
A chemical toolbox for the study of bromodomains and epigenetic signaling.
Nat Commun. 2019 Apr 23;10(1):1915. doi: 10.1038/s41467-019-09672-2.
7
8
Carnosol induces ROS-mediated beclin1-independent autophagy and apoptosis in triple negative breast cancer.
PLoS One. 2014 Oct 9;9(10):e109630. doi: 10.1371/journal.pone.0109630. eCollection 2014.
9
Clinical characteristics and prognostic analysis of triple-negative breast cancer patients.
Mol Clin Oncol. 2014 Mar;2(2):245-251. doi: 10.3892/mco.2013.230. Epub 2013 Dec 20.
10
TNF-α gene knockout in triple negative breast cancer cell line induces apoptosis.
Int J Mol Sci. 2012 Dec 24;14(1):411-20. doi: 10.3390/ijms14010411.

本文引用的文献

4
The prognostic importance of triple negative breast carcinoma.
Breast. 2008 Aug;17(4):341-6. doi: 10.1016/j.breast.2007.11.031. Epub 2008 May 1.
7
Triple-negative breast cancer: clinical features and patterns of recurrence.
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34. doi: 10.1158/1078-0432.CCR-06-3045.
8
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
Clin Cancer Res. 2007 Apr 15;13(8):2329-34. doi: 10.1158/1078-0432.CCR-06-1109.
10
Triple-negative breast cancer: therapeutic options.
Lancet Oncol. 2007 Mar;8(3):235-44. doi: 10.1016/S1470-2045(07)70074-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验